Pharmaceutical

RECORDATI SUBMITS FILE FOR APPROVAL OF SILODOSIN TO THE EMEA

Gen-Probe's CE-marked APTIMA HPV assay may be an important new molecular tool to more accurately detect high-risk human papillomavirus infections that are associated with cervical cancer or precancerous lesions, according to nine oral presentations and t

Basilea Pharmaceutica Ltd. announces that Zevtera , the first-in-class anti-MRSA broad-spectrum cephalosporin, received a positive opinion from the Committee for Medicinal Products for Human Use for the treatment of complicated skin and soft tissue infec

Epeius Biotechnologies announced today the results of Phase I/II and II studies of Rexin-G in chemotherapy-resistant metastatic soft tissue sarcoma and osteosarcoma, as presented by Dr. Sant P. Chawla, principal investigator, at the CTOS 14th annual meet

Epeius Biotechnologies announced today the results of Phase I/II and II studies of Rexin-G in chemotherapy-resistant metastatic soft tissue sarcoma and osteosarcoma, as presented by Dr. Sant P. Chawla, principal investigator, at the CTOS 14th annual mee

ReachMD, the first satellite radio channel created for medical professionals by medical professionals, announced today their newest strategic programming partnership with the American Medical Directors Association , the professional association of medica

The National Minority Quality Forum today applauded the American Medical Association's recent decision to develop a Health Insurer Code of Conduct and called on physician and patient advocates to join the Forum in encouraging adoption and compliance by h

BioSpecifics Technologies Corp. , a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Thomas Wegman, will present at the upcoming Piper Jaffray 20th Annual Health Care Conference